Ghilezan N
J Radiol Electrol Med Nucl. 1977 May;58(5):353-8.
The effectiveness of cobalt therapy for carcinoma of the larynx in demonstrated by the results obtained: 53% overall survival at 5 years, with 66% for carcinomas of the glottis, and 48% for supra-glottal lésions. The dose-time ratio used was adapted to the tumor category and to the individual reactivity of the patients, local control being obtained in 100, 87, 65 and 25% for T1, T2, T3 and T4 tumours respectively.
5年总生存率为53%,声门癌为66%,声门上病变为48%。所采用的剂量-时间比根据肿瘤类别和患者的个体反应性进行调整,T1、T2、T3和T4肿瘤的局部控制率分别为100%、87%、65%和25%。